HHS proposed changes that would roll back many Biden-era policies, eliminate most health tech certification criteria,and ...
Eli Lilly announced a partnership with Walmart on Wednesday to expand access to its GLP-1 Zepbound through LillyDirect, marking LillyDirect’s first retail collaboration. LillyDirect is Eli Lilly’s ...
Like most industries, healthcare is experiencing financial pressure and unprecedented AI advancements. Organizations are also grappling with a political and economic environment that is more dynamic ...
Peptide drugs, such as the metabolic medicines Mounjaro and Zepbound from Eli Lilly, must be administered as injections. But the biotech industry has been pursuing ways to make peptides into pills, ...
We are only two weeks into 2025, and a small handful of healthcare AI companies have already announced funding rounds exceeding $100 million — signaling a strong start to what investors predicted ...
Schizophrenia is currently treated with older medications with limited efficacy and troublesome side effects that lead many patients to stop taking them. The FDA has approved a novel Bristol Myers ...
Morgan Health made a $25 million investment in Merative, a data, analytics and technology provider, the companies announced Tuesday. Washington, D.C.-based Morgan Health is a JPMorgan Chase business ...
PCR is a mainstay in diagnostics, but whether a sample is collected at a clinic or at home, such tests require sending a sample to a lab and then waiting for results. A new FDA authorized ...
Across the healthcare industry, patients are demanding more transparency. They want control over their health and access to their healthcare data. And they’re right – patients should be at the center ...
An experimental GLP-1 obesity drug from Terns Pharmaceuticals led to a 5.5% reduction in body weight in a small study, continuing to build its case as a potential oral alternative to currently ...
Boehringer Ingelheim established a presence in idiopathic pulmonary fibrosis years ago with a drug that has become a standard treatment for this serious lung disorder. Now the company has the ...
Wearable technology that measures people’s physiological data has gotten quite small over the past decade — with some devices now the size of a mere ring or a watch. That’s not an unequivocally good ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results